Post by
ENEMENEMYNEMO on May 09, 2022 7:22am
Some news finally!
Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study
Comment by
Frogprince on May 09, 2022 10:20am
Good news DM was not mentioned and the Quote was from Ever send.Maybe we are seeing DM move back.